Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: August 2010


Related content

Powered by UNSILO
Suggested reading
Asconapé, JJ, Penry, JK, Dreifuss, FE, Riela, A, Mirza, W. Valproate-associated pancreatitis. Epilepsia 1993; 34: 177–183.
Biton, V, Mirza, W, Montouris, G, Vuong, A, Hammer, AE, Barrett, PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001; 56: 172–177.
Bryant, AE, Dreifuss, FE. Valproic acid hepatic fatalities. III. U.S. experience since 1986. Neurology 1996; 46: 465–469.
Glaucer, TA, Cnaan, A, Shinnar, S, Hirtz, DG, Dlugos, D, Masur, D, Clark, PO, Capparelli, EV, Adamson, PC. For the Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. New England Journal of Medicine 2010; 362: 790–799.
Limdi, NA, Shimpi, AV, Faught, E, Gomez, CR, Burneo, JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology 2005; 64: 353–355.
Marson, AG, Williamson, PR, Clough, H, Hutton, JL, Chadwick, DW; Epilepsy Monotherapy Trial Group. Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia 2002; 43: 505–513.
Mattson, RH, Cramer, JA, Collins, JF; Dept. of VA Epilepsy Cooperative Study No. 264 Group. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. New England Journal of Medicine 1992; 327: 765–771.
Patsalos, PN. Anti-epileptic drug interactions. A clinical guide. Clarius Press: Guildford, UK; 2005.
Patsalos, PN, Berry, DJ, Bourgeois, BF, Cloyd, JC, Glauser, TA, Johannessen, SI, Leppik, IE, Tomson, T, Perucca, E. Antiepileptic drugs – Best practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 2008; 49: 1239–1276.
Ramsey, RE, Wilder, BJ, Murphy, JV, Holmes, GL, Uthman, B. Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures. Journal of Epilepsy 1992; 5: 55–60.
Sommerville, KS, Dutta, S, Biton, V, Zhang, Y, Cloyd, JC, Uthman, B. Bioavailability of a divalproex extended-release formulation versus the conventional divalproex formulation in adult patients receiving enzyme-inducing antiepileptic drugs. Clinical Drug Investigation 2003; 23: 661–670.
Villareal, HJ, Wilder, BJ, Willmore, LJ, Bauman, AW, Hammond, EJ, Bruni, J. Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 1978; 28: 886–891.
Wyszynski, DF, Nambisan, M, Surve, T, Alsdorf, RM, Smith, CR, Holmes, LB. Antiepileptic drug pregnancy registry. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 2005; 64: 961–965.